By Rosanne FohnStacey Young-McCaughan, RN, Ph.D.
|Stacey Young-McCaughan, RN, Ph.D., is director of research for STRONG STAR, a multidisciplinary and multi-institution consortium based in the Department of Psychiatry at the UT Health Science Center San Antonio. The consortium conducts research on how to better understand, prevent and treat post-traumatic stress disorder. |
Printer Friendly Format
, a professor in the School of Medicine, was honored March 21 by the White House as a Women Veteran Leader Champion of Change. PTSD research consortia
The retired Army colonel serves as director of research for the STRONG STAR
consortium. STRONG STAR, or the South Texas Research Organizational Network Guiding Studies on Trauma and Resilience, is a multidisciplinary and multi-institutional research consortium designed to understand, prevent and treat combat-related post-traumatic stress disorder (PTSD) and other conditions often associated with PTSD.
The consortium employs primariy two types of cognitive-behavioral therapy &151; Prolonged Exposure and and Cognitive Processing Therapy &151; that have been shown in research studies to treat 80 percent of civilians to the point of remission.
The consortium is conducting 25 clinical trials in Central and South Texas evaluating PE, CPT and similar therapies in active-duty military and recently discharged veterans who served in Afghanistan and Iraq.
Genetic, epidemiological and biological studies also are underway to learn more about biological influences on PTSD and related conditions to develop new and improved prevention and treatment methods. More than $100 million for PTSD research
Alan Peterson, Ph.D., professor of psychiatry and chief of the Division of Behavioral Medicine in the School of Medicine, directs STRONG STAR, related PTSD studies and the Consortium to Alleviate PTSD (CAP), all funded by more than $100 million from the Department of Defense, Veterans Administration and other funding sources.
Guided by a government steering committee, the CAP is charged with addressing research gaps and developing and evaluating new diagnostics, therapeutics and preventions for PTSD and conditions associated with it, emphasizing genetic and biological markers. For more information